[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate

Modify Date: 2024-01-10 15:15:43

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure
[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate structure
Common Name [4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate
CAS Number 2115-48-2 Molecular Weight 484.75300
Density 1.02g/cm3 Boiling Point 542.1ºC at 760 mmHg
Molecular Formula C32H52O3 Melting Point N/A
MSDS N/A Flash Point 223.9ºC

 Names

Name [4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate

 Chemical & Physical Properties

Density 1.02g/cm3
Boiling Point 542.1ºC at 760 mmHg
Molecular Formula C32H52O3
Molecular Weight 484.75300
Flash Point 223.9ºC
Exact Mass 484.39200
PSA 43.37000
LogP 8.30880
Vapour Pressure 8.14E-12mmHg at 25°C
Index of Refraction 1.517

 Synthetic Route

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Brieskorn,C.H.; Dertinger,G. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft, 1970 , vol. 303, p. 960 - 967

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Barton,D.H.R. et al. Journal of the Chemical Society, 1963 , p. 3675 - 3691

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Brieskorn,C.H.; Dertinger,G. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft, 1970 , vol. 303, p. 960 - 967

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Marker; Wittle; Mixon Journal of the American Chemical Society, 1937 , vol. 59, p. 1368,1371

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Mijovic et al. Helvetica Chimica Acta, 1952 , vol. 35, p. 964,971

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Horn; Ilse Journal of the Chemical Society, 1957 , p. 2280

~%

[4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate Structure

[4,4,10,13,14-p...

CAS#:2115-48-2

Literature: Horn; Ilse Journal of the Chemical Society, 1957 , p. 2280